
Moderna (MRNA) is a strong biotechnology opportunity following successful Phase 3 trial results for its AI-designed mRNA-4157 melanoma vaccine, confirming clinical validation for personalized medicine beyond infectious diseases. Demand for NVIDIA (NVDA) remains robust as newly released open-source models require high-memory hardware like the RTX 4090 and RTX 5090 for local computing. Position for potential near-term upside in Meta Platforms (META) ahead of next month's Meta Connect catalyst and the rollout of its desktop Meta AI software. Salesforce (CRM) offers solid enterprise growth potential as it strengthens customer retention by deploying autonomous AI agents directly into Slack. Meanwhile, Alphabet (GOOGL) and Alibaba (BABA) are aggressive buys in the AI software race as they expand global adoption through student promotions and accessible open-weight models.

By @mreflow
AI News Breakdowns every Saturday and other cool nerdy tech and AI stuff in between. Let's work together! - For brand ...